Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Davis

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
Gene Therapy|May 29, 2002
Application of SFHR to gene therapy of monogenic disordersK K Goncz, N L Prokopishyn, B L Chow, et al.
Blood|December 15, 1992
tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppressionG Zauli, B R Davis, M C Re, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 19, 1999
Microcatheter adhesion of cyanoacrylates: comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylateJ D Barr, E J Hoffman, B R Davis, et al.
Annals of Internal Medicine|July 1, 1983
Yersinia enterocolitica pharyngitisC O Tacket, B R Davis, G P Carter, et al.
Angiology|June 1, 1996
Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) StudyT J Wilt, B R Davis, D G Meyers, et al.
Anticancer Research|September 1, 1992
An experimental model for the study of thermochemotherapy in vivoD R Coil, B C Giovanella, P J Greeff, et al.
Cancer|June 1, 1985
Cytophagic histiocytic panniculitis. A variant of malignant histiocytosisD R Barron, B R Davis, J R Pomeranz, et al.
The Pharmacogenomics Journal|November 20, 2002
Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) studyD K Arnett, E Boerwinkle, B R Davis, et al.
Controlled Clinical Trials|December 1, 1996
Decision rules for predicting future lipid values in screening for a cholesterol reduction clinical trialL A Moyé, B R Davis, F Sacks, et al.
The Journal of Investigative Dermatology|June 1, 1991
Patterns of glycosaminoglycan/proteoglycan immunostaining in human skin during agingM D Willen, J M Sorrell, C C Lekan, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Gene Therapy|May 29, 2002
Application of SFHR to gene therapy of monogenic disordersK K Goncz, N L Prokopishyn, B L Chow, et al.
Blood|December 15, 1992
tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppressionG Zauli, B R Davis, M C Re, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 19, 1999
Microcatheter adhesion of cyanoacrylates: comparison of normal butyl cyanoacrylate to 2-hexyl cyanoacrylateJ D Barr, E J Hoffman, B R Davis, et al.
Annals of Internal Medicine|July 1, 1983
Yersinia enterocolitica pharyngitisC O Tacket, B R Davis, G P Carter, et al.
Angiology|June 1, 1996
Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) StudyT J Wilt, B R Davis, D G Meyers, et al.
Anticancer Research|September 1, 1992
An experimental model for the study of thermochemotherapy in vivoD R Coil, B C Giovanella, P J Greeff, et al.
Cancer|June 1, 1985
Cytophagic histiocytic panniculitis. A variant of malignant histiocytosisD R Barron, B R Davis, J R Pomeranz, et al.
The Pharmacogenomics Journal|November 20, 2002
Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) studyD K Arnett, E Boerwinkle, B R Davis, et al.
Controlled Clinical Trials|December 1, 1996
Decision rules for predicting future lipid values in screening for a cholesterol reduction clinical trialL A Moyé, B R Davis, F Sacks, et al.
The Journal of Investigative Dermatology|June 1, 1991
Patterns of glycosaminoglycan/proteoglycan immunostaining in human skin during agingM D Willen, J M Sorrell, C C Lekan, et al.
Pageof 18